 MARIETTA, Ga., Jan. 04, 2022 GLOBE NEWSWIRE -- MiMedx Group, Inc. Nasdaq: MDXG MIMEDX or the Company, a transformational placental biologics company, today announced that Timothy R. Wright, Chief Executive Officer, Peter M. Carlson, Chief Financial Officer, and Robert B. Stein, M.D., Ph.D., Executive Vice President, Research and Development, will participate in a fireside chat at the H.C. Wainwright BioConnect Virtual Conference taking place January 10-13, 2022. 